Testing effectiveness (Phase 2)Study completedNCT00443326What this trial is testingAMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis SubjectsWho this might be right forPsoriasis Amgen 22
Testing effectiveness (Phase 2)Study completedNCT00410163What this trial is testingOfatumumab With Fludarabine and Cyclophosphamide in B-CLL PatientsWho this might be right forLeukaemia, Lymphocytic, Chronic GlaxoSmithKline 61
Early research (Phase 1)Study completedNCT02262338What this trial is testingSafety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter SyndromeWho this might be right forMucopolysaccharidosis II ArmaGen, Inc 6
Early research (Phase 1)Study completedNCT04408963What this trial is testingTrial to Evaluate CAP256V2LS in Healthy AdultsWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT02494206What this trial is testingImmunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)Who this might be right forBreast CancerUpper Extremity Lymphedema Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)UnknownNCT00066547What this trial is testingMonoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination ChemotherapyWho this might be right forBreast Cancer Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT01676948What this trial is testingAn Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)Who this might be right forSystemic Juvenile Idiopathic Arthritis Novartis Pharmaceuticals
Early research (Phase 1)UnknownNCT03487055What this trial is testingSafety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone MetastasesWho this might be right forBreast Cancer Jiangsu T-Mab Biopharma Co.,Ltd 30
Large-scale testing (Phase 3)Study completedNCT00712933What this trial is testingA Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057Who this might be right forSystemic Lupus Erythematosus Human Genome Sciences Inc., a GSK Company 738
Early research (Phase 1)Study completedNCT03763149What this trial is testingA Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and LymphomasWho this might be right forAdvanced Malignancies Innovent Biologics (Suzhou) Co. Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT00732940What this trial is testingPhase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus Human Genome Sciences Inc. 56
Early research (Phase 1)Study completedNCT01005355What this trial is testingStudy of IMC-1121B in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Eli Lilly and Company 15
Early research (Phase 1)Study completedNCT03207191What this trial is testingTrial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myeloid Leukemia (AML) Relapse Philogen S.p.A. 15
Testing effectiveness (Phase 2)Ended earlyNCT01757197What this trial is testingPhase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)Who this might be right forGlucocorticosteroid Refractory Acute GVHD Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)Study completedNCT03033524What this trial is testingTrial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma PharmAbcine 12
Testing effectiveness (Phase 2)Study completedNCT01222286What this trial is testingStudy on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple MyelomaWho this might be right forSmoldering Multiple Myeloma Innate Pharma 30
Testing effectiveness (Phase 2)Study completedNCT01134250What this trial is testingCombination Therapy of F16IL2 and Paclitaxel in Solid Tumour PatientsWho this might be right forSolid TumorBreast CancerMetastatic Melanoma+1 more Philogen S.p.A. 48
Early research (Phase 1)Study completedNCT00923169What this trial is testingPart 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)Who this might be right forRenal Cell Carcinoma National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00656890What this trial is testingMDX-1100 in Subjects With Active Ulcerative ColitisWho this might be right forUlcerative Colitis Bristol-Myers Squibb 110
Early research (Phase 1)Active Not RecruitingNCT03843359What this trial is testingA First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 97